$87.98
3.53% yesterday
Nasdaq, Jun 10, 10:04 pm CET
ISIN
US4523271090
Symbol
ILMN

Illumina Stock price

$87.98
+6.41 7.86% 1M
-60.55 40.77% 6M
-45.65 34.16% YTD
-19.02 17.77% 1Y
-261.84 74.85% 5Y
-121.93 58.09% 10Y
+82.30 1,450.23% 20Y
Nasdaq, Closing price Tue, Jun 10 2025
+3.00 3.53%
ISIN
US4523271090
Symbol
ILMN
Sector
Industry

Key metrics

Market capitalization $13.93b
Enterprise Value $14.68b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 16.76
EV/Sales (TTM) EV/Sales 3.38
P/S ratio (TTM) P/S ratio 3.21
P/B ratio (TTM) P/B ratio 5.91
Revenue growth (TTM) Revenue growth -3.47%
Revenue (TTM) Revenue $4.34b
EBIT (operating result TTM) EBIT $914.00m
Free Cash Flow (TTM) Free Cash Flow $876.00m
Cash position $1.24b
EPS (TTM) EPS $-6.06
P/E forward 23.25
P/S forward 3.30
EV/Sales forward 3.47
Short interest 5.90%
Show more

Is Illumina a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,838 stocks worldwide.

Illumina Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a Illumina forecast:

11x Buy
44%
12x Hold
48%
2x Sell
8%

Analyst Opinions

25 Analysts have issued a Illumina forecast:

Buy
44%
Hold
48%
Sell
8%

Financial data from Illumina

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,337 4,337
3% 3%
100%
- Direct Costs 1,460 1,460
16% 16%
34%
2,877 2,877
4% 4%
66%
- Selling and Administrative Expenses 889 889
40% 40%
20%
- Research and Development Expense 1,074 1,074
19% 19%
25%
1,229 1,229
228% 228%
28%
- Depreciation and Amortization 315 315
27% 27%
7%
EBIT (Operating Income) EBIT 914 914
1,676% 1,676%
21%
Net Profit -965 -965
25% 25%
-22%

In millions USD.

Don't miss a Thing! We will send you all news about Illumina directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Illumina Stock News

Neutral
PRNewsWire
about 15 hours ago
SAN DIEGO , June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of genomics, today published its annual Corporate Social Responsibility (CSR) Report. The report spotlights the ways Illumina is making precision health more accessible than ever before, and its ongoing work to empower people and communities, embed sustainability across its ...
Neutral
PRNewsWire
13 days ago
New AI algorithm accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome at scale for the first time SAN DIEGO , May 29, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today unveiled PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. A study published to...
Neutral
Seeking Alpha
13 days ago
Illumina, Inc. (NASDAQ:ILMN ) Bernstein 41st Annual Strategic Decisions Conference Call May 28, 2025 2:30 PM ET Company Participants Jacob Thaysen - Chief Executive Officer Conference Call Participants Eve Burstein - Bernstein Eve Burstein All right. Thank you so much, everyone, for joining.
More Illumina News

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Head office United States
CEO Jacob Thaysen
Employees 9,000
Founded 1998
Website www.illumina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today